Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Systolic Heart Failure: later-stage trial registry
2 of 4 indexed Systolic Heart Failure trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Systolic Heart Failure: 4 US clinical trials tracked, 2 recruiting.
Systolic Heart Failure is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Nebraska, running 1 of these trials.
Enrollment posture brief
Registry condition systolic-heart-failure
OPEN 2 | RECR 50% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Systolic Heart Failure lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Systolic Heart Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Systolic Heart Failure is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Neuromodulation of Inflammation and Endothelial Function
University of Oklahoma
NCT05230732
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
Yale University
NCT06671015
Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
National Heart, Lung, and Blood Institute (NHLBI)
NCT01932294
Platelet Inhibition in Patients With Systolic Heart Failure
University of Nebraska
NCT01765400
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Systolic Heart Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Systolic Heart Failure trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Systolic Heart Failure page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Systolic Heart Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Nebraska sponsors the most Systolic Heart Failure trials on record, review their full trial history before evaluating a specific study. See University of Nebraska's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Systolic Heart Failure condition card totals 4 registered trials; most-linked intervention Clopidogrel 75 mg daily x 2 weeks; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.